Published in J Lab Clin Med on July 01, 1978
Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture. J Clin Invest (1979) 1.73
Increased expression of integrin alphavbeta5 induces the myofibroblastic differentiation of dermal fibroblasts. Am J Pathol (2006) 1.46
Smooth muscle differentiation in scleroderma fibroblastic cells. Am J Pathol (1990) 1.36
Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. J Clin Invest (2004) 1.32
Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A. J Clin Invest (1999) 1.29
Progressive systemic sclerosis of the internal anal sphincter leading to passive faecal incontinence. Gut (1994) 0.99
Increased expression levels of integrin alphavbeta5 on scleroderma fibroblasts. Am J Pathol (2004) 0.98
Systemic sclerosis: a collagen or microvascular disease? Br Med J (Clin Res Ed) (1984) 0.95
Persistence of a reduced-collagen-producing phenotype in cultured scleroderma fibroblasts after short-term exposure to interferons. J Clin Invest (1987) 0.94
Interstitial lung disease in systemic sclerosis. Lung (2007) 0.94
Differential regulation of glycosaminoglycan, fibronectin, and collagenase production in cultured human dermal fibroblasts by interferon-alpha, -beta, and -gamma. Arch Dermatol Res (1989) 0.93
Scleroderma fibroblasts: some aspects of in vitro assessment of collagen synthesis. Arch Dermatol Res (1981) 0.89
Collagen synthesis in scleroderma: selection of fibroblast populations during subcultures. Arch Dermatol Res (1985) 0.85
Functional and phenotypic analysis of T lymphocytes cloned from the skin of patients with systemic sclerosis. Clin Exp Immunol (1990) 0.85
Proteomic analysis identification of a pattern of shared alterations in the secretome of dermal fibroblasts from systemic sclerosis and nephrogenic systemic fibrosis. Am J Pathol (2010) 0.84
Animal model of human disease. Avian scleroderma. An inherited fibrotic disease of white Leghorn chickens resembling progressive systemic sclerosis. Am J Pathol (1985) 0.80
Pharmacodynamic effect of dipyridamole on thallium-201 myocardial perfusion in progressive systemic sclerosis with diffuse scleroderma. Ann Rheum Dis (1986) 0.79
Collagen synthesis in generalized morphea. Arch Dermatol Res (1983) 0.79
Defective Epstein-Barr virus specific suppressor T cell function in progressive systemic sclerosis. Ann Rheum Dis (1986) 0.78
Alterations in intracellular calcium transients of fibroblasts from progressive systemic sclerotic patients: a digital imaging microscopic study. Arch Dermatol Res (1991) 0.77
Histomorphometric analysis of cutaneous remodeling in the early stage of the scleroderma model. Clinics (Sao Paulo) (2009) 0.76
Reduced response of scleroderma fibroblasts to fibroblast growth factor. Arch Dermatol Res (1984) 0.75
Enzyme activities involved in connective tissue metabolism in the skin of tight-skin (TSK) mice. Arch Dermatol Res (1986) 0.75
Decreased bradykinin binding sites in fibroblasts from progressive systemic scleroderma. Arch Dermatol Res (1994) 0.75
Pulmonary renal syndromes. II. Etiology and pathogenesis. Yale J Biol Med (1982) 0.75
Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum (1980) 3.87
Anticoagulation in patients with atrial fibrillation. GPs not prepared for monitoring anticoagulation. BMJ (1993) 2.49
Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma). Arthritis Rheum (1968) 2.30
Biotransformation of hydrocarbons and related compounds by whole organism suspensions of methane-grown methylosinus trichosporium OB 3b. Biochem Biophys Res Commun (1979) 2.22
Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. Arthritis Rheum (1984) 2.17
Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum (1980) 2.13
Eosinophilic fasciitis. A pathologic study of twenty cases. Am J Pathol (1979) 2.02
Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med (1971) 2.00
D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis. Ann Intern Med (1982) 1.84
Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum (1986) 1.72
Genetic pathways of colorectal carcinogenesis rarely involve the PTEN and LKB1 genes outside the inherited hamartoma syndromes. Am J Pathol (1998) 1.67
Giant synovial cysts of the calf in patients with rheumatoid arthritis. J Bone Joint Surg Am (1968) 1.62
A Case of Defective Articulation. Med Chir Trans (1891) 1.60
Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). Ann Intern Med (1977) 1.57
Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum (1979) 1.57
Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma). J Clin Invest (1976) 1.55
Optimal switching to diapause in relation to the onset of winter. Theor Popul Biol (1980) 1.54
Hemorrhagic shock and encephalopathy: clinical, pathologic, and biochemical features. J Pediatr (1989) 1.50
Guidelines for anticoagulation. BMJ (1994) 1.50
Audit of start of anticoagulation treatment in inpatients. J Clin Pathol (1993) 1.49
A brief history of the rheumatic diseases. Bull Rheum Dis (1982) 1.46
The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis. Ann Intern Med (1967) 1.45
Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases. Medicine (Baltimore) (1983) 1.44
Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease. Arthritis Rheum (1985) 1.42
Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon. Medicine (Baltimore) (1980) 1.39
Frequency and severity of infections in day care. J Pediatr (1988) 1.38
Effect of food, fast and alcohol on serum uric acid and acute attacks of gout. Am J Med (1967) 1.38
Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum (1984) 1.35
Parental and physician-related determinants of consent for neonatal autopsy. Am J Dis Child (1987) 1.34
Letter: HL-A antigens in progressive systemic sclerosis (scleroderma). Arthritis Rheum (1975) 1.33
Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1). Headache (2000) 1.33
The rheumatic manifestaions of progressive systemic sclerosis (scleroderma). Clin Orthop Relat Res (1968) 1.30
Clinical spectrum of connective tissue disease after cosmetic surgery. Observations on eighteen patients and a review of the Japanese literature. Arthritis Rheum (1984) 1.30
Measurement of circumference of the knee with ordinary tape measure. Ann Rheum Dis (1976) 1.26
Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med (1984) 1.26
Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med (1984) 1.26
Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum (1985) 1.21
Abnormalities of T lymphocyte subsets in patients with progressive systemic sclerosis (PSS, scleroderma). J Lab Clin Med (1981) 1.21
Selection and properties of Escherichia coli mutants defective in the synthesis of cyclopropane fatty acids. J Bacteriol (1976) 1.20
IMPAIRMENT OF URIC ACID EXCRETION IN GOUT. J Clin Invest (1962) 1.18
The early history of antirheumatic drugs. Arthritis Rheum (1970) 1.17
Skeletal muscle involvement in progressive systemic sclerosis (scleroderma). Arthritis Rheum (1968) 1.17
Anemia and scleroderma: frequency, causes, and marrow findings. Arch Intern Med (1968) 1.17
Induction of matrix metalloproteinase-2 and -3 activity in ovine nucleus pulposus cells grown in three-dimensional agarose gel culture by interleukin-1beta: a potential pathway of disc degeneration. Eur Spine J (2002) 1.17
Hyaluronic acid in human synovial effusions; a sensitive indicator of altered connective tissue cell function during inflammation. Arthritis Rheum (1966) 1.14
The ultrastructure of skin in progressive systemic sclerosis (scleroderma). I. Dermal collagen fibers. Am J Pathol (1971) 1.13
Serum anti-gamma-globulin and antinuclear factors in the aged. JAMA (1967) 1.13
Collagen types synthesized in dermal fibroblast cultures from patients with early progressive systemic sclerosis. Arthritis Rheum (1980) 1.11
The early history of synovia (joint fluid). Ann Intern Med (1966) 1.11
Family physicians and first-trimester abortion: a survey of residency programs in southern California. Fam Med (1994) 1.11
A study of polymorphism in the circumsporozoite protein of human malaria parasites. Am J Trop Med Hyg (1994) 1.10
Chromosome abnormalities from cyclophosphamide therapy in rheumatoid arthritis and progressive systemic sclerosis (scleroderma). Arthritis Rheum (1974) 1.07
Allopurinol and gouty hyperuricemia. Efficacy of a single daily dose. JAMA (1975) 1.06
Effects of rheumatoid sera on fibroblast proliferation and hyaluronic acid synthesis. Arthritis Rheum (1968) 1.06
Prophylactic methicillin for shunt operations: effects on incidence of shunt malfunction and infection. Childs Brain (1982) 1.04
Palmar fasciitis and arthritis with malignant neoplasms: a paraneoplastic syndrome. Semin Arthritis Rheum (1986) 1.03
Prognostic factors in mobile tongue and floor of mouth carcinoma. Cancer (1989) 1.03
Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma. Chest (1983) 1.03
The effect of bacterial products on synovial fibroblast function: hypermetabolic changes induced by endotoxin. J Clin Invest (1972) 1.02
Sjögren's syndrome in progressive systemic sclerosis. Ann Intern Med (1977) 1.02
Moderate and severe reactions in blood donors. Transfusion (1992) 1.01
Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med (1986) 0.99
Cellular immunity in progressive systemic sclerosis (scleroderma). Ann Rheum Dis (1972) 0.99
Thyroid disease in progressive systemic sclerosis: increased frequency of glandular fibrosis and hypothyroidism. Ann Intern Med (1981) 0.98
Soluble mediators from mononuclear cells increase the synthesis of glycosaminoglycan by dermal fibroblast cultures derived from normal subjects and progressive systemic sclerosis patients. Arthritis Rheum (1985) 0.98
Progressive systemic sclerosis (PSS, scleroderma) dermal fibroblasts synthesize increased amounts of glycosaminoglycan. J Lab Clin Med (1983) 0.98
Clinical and serologic study of Sjögren's syndrome in patients with progressive systemic sclerosis. Arthritis Rheum (1983) 0.97
Septic rheumatoid pericarditis complicating Felty's syndrome. Arthritis Rheum (1981) 0.96
Histocompatibility antigens in progressive systemic sclerosis (scleroderma). J Rheumatol (1977) 0.96
Bleomycin-induced scleroderma. J Rheumatol (1981) 0.96
Vitamin C and acute illness in Navajo school children. N Engl J Med (1976) 0.96
Search for the rare leptonic decay B--->tau-nutau. Phys Rev Lett (2005) 0.96
Hippocrates, Galen, and synovia. Ann Intern Med (1972) 0.95
Cytokine production and serum levels in systemic sclerosis. Clin Immunol Immunopathol (1992) 0.95
Signorina Galieri's scleroderma or scleredema. Ann Intern Med (1972) 0.95
Dietary intake and nutritional treatment in childhood Crohn's disease. J Pediatr Gastroenterol Nutr (1993) 0.95
Bursitis and tendinitis. Compr Ther (1981) 0.94
Ultrastructural studies in hypertension. II. Renal vascular changes in progressive systemic sclerosis. Lab Invest (1966) 0.93
Proceedings: Eosinophilic fasciitis. Report of six cases of a newly recognized scleroderma-like syndrome. Arthritis Rheum (1976) 0.93
Suppressor cell function and T lymphocyte subpopulations in peripheral blood of patients with progressive systemic sclerosis. Arthritis Rheum (1983) 0.92
Immune complexes in progressive systemic sclerosis (scleroderma). Arthritis Rheum (1982) 0.91
Radiotherapy of nonfunctional adenomas of the pituitary gland. Results with long-term follow-up. Cancer (1989) 0.91
The effect of D-penicillamine on pulmonary findings in systemic sclerosis. Arthritis Rheum (1985) 0.91
Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma). J Clin Immunol (1982) 0.90
Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease. Gut (1993) 0.90
Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer. Br J Surg (2011) 0.90
Anaerobic glycolysis and lactate dehydrogenase (LDH) isoenzymes in articular cartilage. J Lab Clin Med (1969) 0.90
Polyarthritis associated with type IV hyperlipoproteinemia. Arch Intern Med (1975) 0.89
Paediatric and perinatal HIV/AIDS in Jamaica an international leadership initiative, 2002-2007. West Indian Med J (2008) 0.89